Biotech Cluster Bay Area and Switzerland – a Comparison English (PDF) – 3 pages 116kb
Comparison of early stage funding in the US and EU – who gets more money?
Comparison of early stage funding in the US and EU – who gets more money? English (PDF) – 3 pages 172kb
BIO-Europe 2011: Early Stage Oncology Deals
Top Value drivers in the Life Science Industry
VC Deal Summary August 2011
Interviews with leading Life Sciences companies: Next Energy & Resouces Co. Ldt.
Interviews with leading Life Sciences companies: Next Energy & Resouces Co. Ldt. English (PDF) – 3 pages – 791kb
VC Deal Summary June 2011
BIO 2011: Deal-making in the Antibody Space
Keeping up with the Biotech industry
Real time access to the dynamic data used to generate reports is a clear advantage allowing you to see trends as they develop instead of being limited to a snapshot view of one point in time. Read this article to learn how you can access the information behind the statistics reports in real-time. By Jost … Continue reading Keeping up with the Biotech industry
Deal-making in the Antibody Space
More than 150 antibody products and technologies will be offered for partnering at the BIO International convention later this month. Since knowledge of historical deal information is a crucial prerequisite for deal negotiation, we have examined over 150 therapeutic antibody deals listed in the Biotechgate Licensing Deals database to compile this detailed analysis as well … Continue reading Deal-making in the Antibody Space